DRAMAMINE- meclizine hydrochloride tablet, chewable
Medtech Products Inc.
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Meclizine HCl 25 mg
for prevention and treatment of these symptoms associated with motion sickness:
■nausea ■vomiting ■dizziness
children under 12 years of age unless directed by a doctor
■a breathing problem such as emphysema or chronic bronchitis
■trouble urinating due to an enlarged prostate gland
sedatives or tranquilizers
■drowsiness may occur
■avoid alcoholic drinks
■alcohol, sedatives, and tranquilizers may increase drowsiness
■be careful when driving a motor vehicle or operating machinery
ask a doctor before use.
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
■to prevent motion sickness take first dose ½ hour to 1 hour before activity that may result in nausea
■to treat motion sickness, take at first signs of symptoms
■adults and children 12 years and over: 1 to 2 tablets once daily, or as directed by a doctor
■store at room temperature 20°–25°C (68°-77°F)
croscarmellose sodium, crospovidone, FD&C red #40 lake, lactose, magnesium stearate, raspberry flavor, silica, sodium saccharin, stearic acid, vanilla flavor
All Day Less Drowsy Chewable Formula
Meclizine HCl 25 mg /Motion Sickness Relief
12 Raspberry Cream Flavored Chewable Tablets (25mg EACH)
| DRAMAMINE |
meclizine hydrochloride tablet, chewable
|Labeler — Medtech Products Inc. (122715688)|
Revised: 07/2019 Medtech Products Inc.
DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.